Fed Circ panel reviews $235m GSK award over ‘skinny’ Teva generic
25-02-2021
First Circuit says Actavis pay-for-delay ruling applies to non-cash settlements
23-02-2016
US court says ‘pay-for-delay’ settlements do not need to involve cash
29-06-2015
Roman Sinichkin / Shutterstock.com
The US Federal Trade Commission (FTC) has urged a federal appeals court to correct errors in a judgment from a Pennsylvania court that found the plaintiff in a pay-for-delay case had failed to prove that the agreement breached US competition law.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Federal Trade Commission; pay-for-delay; US Supreme Court; GSK; Teva; Aetna; reverse payment settlement; US Court of Appeals for the Third Circuit;
